Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Safety Profile


gammaCore is not associated with the side effects of traditional medications or cardiac
or respiratory effects

  • gammaCore relies on the activation of afferent A-fibers in the vagus nerve which is not implicated in negative cardiac or respiratory effects.1,2
  • In a IDE, prospective, multi-centered pilot study,* no adverse events were reported during or after stimulation. There were no significant changes in electrocardiogram, heart rate (HR) or systolic or diastolic
    blood pressure (BP).
  • gammaCore should not be used by people with an implanted device such as a pacemaker, hearing aid implant, or any implanted electronic device. It should not be used in people who are diagnosed with narrowing of the arteries (carotid atherosclerosis) or those who have had surgery to cut the vagus nerve in your neck.*
  • Side effects may include hoarseness, shortness of breath, change in voice, & skin irritation. The gammaCore should not be used by people with an implanted device such as a pacemaker, hearing aid implant, or any implanted electronic device. For full prescribing information, refer to the Instructions for Use.

Sources
1. Data on file.
2. Castoro MA, Yoo PB, Hincapie JG, et al. Excitation properties of the right cervical vagus nerve in adult dogs. Exp Neurol. 2011;227(1):62-68.
3. Data on file

gammaCore+logo